<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4002612/" ref="ordinalpos=1414&amp;ncbi_uid=6626579&amp;link_uid=PMC4002612" image-link="/pmc/articles/PMC4002612/figure/fig3/" class="imagepopup">Figure 3.  From: Characterization of a novel curcumin analog P1 as potent inhibitor of the NF-?B <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> with distinct mechanisms. </a></div><br /><div class="p4l_captionBody">P1 exhibited stronger inhibition of the NF-κB signaling pathway than curcumin. (A) The inhibition curve of curcumin on TNF-α (10 ng/mL)-induced NF-κB luciferase activity. Cell viability was examined in parallel with luciferase activity. (B) Dose dependence curve of P1 inhibition of TNF-α-induced NF-κB luciferase activity. Cell viability was examined in parallel with luciferase activity. (C) Time dependence curve of P1 inhibition of TNF-α-induced NF-κB luciferase activity. Cell viability was examined in parallel with luciferase activity. (D) Western blot analysis of the key proteins in the NF-κB pathway after curcumin or P1 treatment for 6 h. Mean±SD. n=3</div></div>